Growth factors and their receptors in neuropathic diabetic foot ulcers of different durations

Growth factors and their receptors in neuropathic diabetic foot ulcers of different durations

BACKGROUND. Growth factors play a leading role in wound healing. Their deficiency in diabetic foot syndrome has been demonstrated in experimental studies, most of them performed on acute wounds. At the same time, currently the effectiveness of local therapy with growth factors of this category of pa...

Full description

Bibliographic Details
Main Authors:	E. Y. Komelyagina, M. B. Antsiferov, E. A. Kogan, N. V. Zharkov
Format:	Article
Language:	English
Published:	Endocrinology Research Centre 2023-08-01
Series:	Сахарный диабет
Subjects:	diabetic foot syndrome heard to heal ulcers growth factors vascular endothelial growth factor insulin-like growth factor epidermal growth factor
Online Access:	https://www.dia-endojournals.ru/jour/article/view/13009

Similar Items

Growth factors in the treatment of diabetic foot syndrome
by: Elena Y. Komelyagina, et al.
Published: (2019-10-01)

Curative Metatarsal Bone Surgery Combined with Intralesional Administration of Recombinant Human Epidermal Growth Factor in Diabetic Neuropathic Ulceration of the Forefoot: A Prospective, Open, Uncontrolled, Nonrandomized, Observational Study
by: Aristides L. Garcia Herrera, MD, PhD, et al.
Published: (2017-01-01)

Salivary Vascular Endothelial Growth Factor and Epidermal Growth Factor Levels in Patients with Recurrent Aphthous Stomatitis: a Meta-Analysis
by: Paria Motahari, et al.
Published: (2023-09-01)

Role of Oligodendrocytes and Myelin in the Pathophysiology of Autism Spectrum Disorder
by: Alma Y. Galvez-Contreras, et al.
Published: (2020-12-01)

Pharmacoeconomic analysis of epidermal growth factor (HeberprotP ®) for the treatment of diabetic foot ulcers
by: G R Galstyan, et al.
Published: (2013-03-01)

Effect of Yinqi ointment on wound morphology and growth factor in treating diabetic foot ulcer
by: Ya-Li Liu, et al.
Published: (2019-01-01)

Anti-inflammatory and immunomodulatory effects of rosuvastatin in patients with low-to-moderate cardiovascular risk
by: VAVLUKIS ANA, et al.
Published: (2022-06-01)

Vascular endothelial growth factor, endostatin levels and clinical features among patients with ulcerative colitis and irritable bowel syndrome and among healthy controls: a cross-sectional analytical study
by: Evrim Kahramanoğlu Aksoy, et al.

Epidermal growth factor outperforms placebo in the treatment of diabetic foot ulcer: a meta-analysis [version 2; peer review: 2 approved]
by: Fazal Rahim, et al.
Published: (2023-03-01)

Novel targeted agents for the treatment of bladder cancer: translating laboratory advances into clinical application
by: Xiaoping Yang, et al.
Published: (2010-06-01)

rhEGF-Loaded Hydrogel in the Treatment of Chronic Wounds in Patients with Diabetes: Clinical Cases
by: Beatriz Guitton Renaud Baptista de Oliveira, et al.
Published: (2022-08-01)

Epidermal and fibroblast growth factor incorporated polyvinyl alcohol electrospun nanofibers as burn wound dressing scaffold.
by: Ismail A. Asiri, Amanah
Published: (2023)

Insulin-like growth factors: Ligands, binding proteins, and receptors
by: Derek LeRoith, et al.
Published: (2021-10-01)

Demonstration of the Effectiveness of Epidermal Growth Factor in Diabetic Foot Ulcers
by: Halit Baykan, et al.
Published: (2022-11-01)

Improvement of developmental competence of aged porcine oocytes by means of the synergistic effect of insulin-like growth factor-1 (IGF-1) and epidermal growth factor (EGF)
by: I. Petrová, et al.
Published: (2005-07-01)

Fibroblast Growth Factor in Diabetic Foot Ulcer: Progress and Therapeutic Prospects
by: Ye Liu, et al.
Published: (2021-10-01)

Versatile Mitogenic and Differentiation‐Inducible Layer Formation by Underwater Adhesive Polypeptides
by: Seiichi Tada, et al.
Published: (2021-08-01)

Current understanding of the role of insulin-like and vascular endothelial growth factors in development, prognosis and targeted therapy in patients with ovarian cancer
by: R I Knyazev, et al.
Published: (2015-09-01)

Long-term Follow-up of treatment of chronic foot wounds with recombinant human epidermal growth factor in patients with different complications of diabetes mellitus
by: E. L. Zaitseva, et al.
Published: (2021-02-01)

Efficacy of Osimertinib Combined with Bevacizumab in Advanced Non-small Cell  Lung Cancer Patients with Acquired EGFR T790M Mutation
by: Yanfei GU, et al.
Published: (2022-12-01)

The effect of human recombinant epidermal growth factor in the treatment of diabetic foot ulcers
by: Mehmet Kadir Bartın, et al.
Published: (2022-05-01)

Healing properties of epidermal growth factor and tocotrienol-rich fraction formulation in deep partial-thickness burn wound model
by: Guo, Hui-Fang
Published: (2017)

IGF-Binding Proteins: Why Do They Exist and Why Are There So Many?
by: John B. Allard, et al.
Published: (2018-04-01)

Bisacurone gel ameliorated burn wounds in experimental rats via its anti-inflammatory, antioxidant, and angiogenic properties
by: Zengqiang Yan, et al.
Published: (2023-08-01)

Streptozotocin induced diabetic retinopathy in rat and the expression of vascular endothelial growth factor and its receptor
by: Chen-Yuan Gong, et al.
Published: (2013-10-01)

Comparative analysis of serum and tumor vascular endothelial growth factor, insulin-like growth factor 1, matrix metalloproteinase 7 levels in patients with ovarian cancer
by: Ya. Z. Plieva, et al.
Published: (2018-01-01)

RELAY, ramucirumab plus erlotinib versus placebo plus erlotinib in patients with untreated, EGFR-mutated, metastatic non-small cell lung cancer: Europe/United States subset analysis
by: S Ponce Aix, et al.
Published: (2021-01-01)

Animal insulin-like growth factor binding proteins and their biological functions
by: Z. Kostecká, et al.
Published: (2002-02-01)

Age-related changes in Folliculogenesis and potential modifiers to improve fertility outcomes - A narrative review
by: Ecem Esencan, et al.
Published: (2022-11-01)

The use of genes for performance enhancement: doping or therapy?
by: R.S. Oliveira, et al.
Published: (2011-12-01)

The use of genes for performance enhancement: doping or therapy?
by: R.S. Oliveira, et al.
Published: (2011-12-01)

Microvascularization and Expression of Fibroblast Growth Factor and Vascular Endothelial Growth Factor and Their Receptors in the Mare Oviduct
by: Pedro Pinto-Bravo, et al.
Published: (2021-04-01)

Risk factors for thromboembolism during first-line treatment of patients with unresectable advanced or recurrent colorectal cancer: a retrospective short study
by: Ryo Takada, et al.
Published: (2023-07-01)

Comparison of EGF with VEGF Non-Viral Gene Therapy for Cutaneous Wound Healing of Streptozotocin Diabetic Mice
by: Junghae Ko, et al.
Published: (2011-06-01)

Biomechanic and histologic analysis of fibroblastic effects of tendon-to-bone healing by transforming growth factor β1 (TGF-β1) in rotator cuff tears
by: Chong Zhang, et al.
Published: (2017-12-01)

Isolation and cloning of human VEGF promoter region in PGL3 basic vector /
by: Iman Yaze, 1982-, et al.
Published: (2011)

Isolation and cloning of human VEGF promoter region in PGL3 basic vector [electronic resource] /
by: Iman Yaze, 1982- author, et al.
Published: (2011)

Vascular Endothelial Growth Factor in Unstimulated Saliva of the Patients with Minor Aphtha
by: S Seifi,, et al.
Published: (2012-09-01)

The role of angiogenic factors in endometrial cancer
by: Monika Magdalena Żyła, et al.
Published: (2014-05-01)

Expressions of vascular endothelial growth factor A, mucin-1, colony-stimulating factor-1, heparin-binding epidermal growth factor-like growth factor, and fibroblast growth factor 2 genes in the female reproductive tracts of women with ectopic pregnancy: A case-control study
by: Sima Golkar, et al.
Published: (2023-11-01)